Gentex director granted 5,626 common shares

WALKER BRIAN C reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

WALKER BRIAN C reported acquisition or exercise transactions in this Form 4 filing.

GENTEX CORP director Brian C. Walker received a stock award of 5,626 shares of common stock as equity compensation. The shares were granted at no cash cost and will vest 100% one year from the grant award date. Following this award, Walker directly holds 29,831 common shares.

Insider Trade Summary

Grant/Award: 5,626 shares

Grant/Award 1 txn

Insider WALKER BRIAN C

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	5,626	$0.00	$0.00

Holdings After Transaction: Common Stock — 29,831 shares (Direct)

Footnotes (1)

1. F1. These shares vest 100% one year from grant award date.

Key Figures

Stock award size: 5,626 shares Grant price per share: $0.00 per share Shares after transaction: 29,831 shares +1 more

4 metrics

Stock award size 5,626 shares Common Stock grant to director Brian C. Walker

Grant price per share $0.00 per share Equity compensation award, no cash paid

Shares after transaction 29,831 shares Total common shares directly held after award

Vesting schedule 100% after one year Newly granted shares vest one year from grant date

Key Terms

Grant, award, or other acquisition, Common Stock, vest 100% one year from grant award date

3 terms

Grant, award, or other acquisition financial

"Transaction code description is “Grant, award, or other acquisition” for the 5,626 shares."

Common Stock financial

"The security title for the transaction is listed as Common Stock."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

vest 100% one year from grant award date financial

"Footnote states these shares vest 100% one year from grant award date."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Gentex (GNTX) director Brian C. Walker report in this Form 4?

Brian C. Walker reported receiving a stock award of 5,626 Gentex common shares. This is an equity compensation grant, not an open-market purchase, and increases his direct holdings to 29,831 shares after the transaction.

Was the Gentex (GNTX) Form 4 transaction a stock purchase or a grant?

The Form 4 shows a grant or award acquisition of 5,626 Gentex common shares, coded as an “A” transaction. Walker did not pay cash for these shares; they were issued as compensation and classified as a non-derivative equity award.

How many Gentex (GNTX) shares does Brian C. Walker own after this award?

After the reported stock award, Brian C. Walker directly holds 29,831 Gentex common shares. This total includes the 5,626 shares granted in the current transaction, as reflected in the post-transaction ownership figure on the Form 4.

What are the vesting terms of Brian C. Walker’s new Gentex (GNTX) shares?

The 5,626 Gentex shares granted to Brian C. Walker vest 100% one year from the grant award date. Until vesting, the award is subject to this time-based condition, as disclosed in the footnote to the Form 4 filing.

What does transaction code “A” mean in the Gentex (GNTX) Form 4 for Brian C. Walker?

Transaction code “A” on the Form 4 indicates a grant, award, or other acquisition of stock. For Brian C. Walker, it represents a compensatory grant of 5,626 Gentex common shares, not an open-market buy or sell transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/22/2026 - 01:41 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WALKER BRIAN C

(Last) (First) (Middle)

600 NORTH CENTENNIAL STREET

(Street)

ZEELAND MICHIGAN 49464

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GENTEX CORP [ GNTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/21/2026		A		5,626(1)	A	$0.00	29,831	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares vest 100% one year from grant award date.

Remarks:

	/s/ Scott Ryan for Brian Walker by Power of Attorney	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)